These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 37130627)
1. Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma. Zeng L; Xu H; Li SH; Xu SY; Chen K; Qin LJ; Miao L; Wang F; Deng L; Wang FH; Li L; Fu S; Liu N; Wang R; Li YQ; Wang HY J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37130627 [TBL] [Abstract][Full Text] [Related]
2. Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis. Wang YQ; Zhang Y; Jiang W; Chen YP; Xu SY; Liu N; Zhao Y; Li L; Lei Y; Hong XH; Liang YL; Li JY; Zhang LL; Yun JP; Sun Y; Li YQ; Ma J J Immunother Cancer; 2019 Nov; 7(1):298. PubMed ID: 31722750 [TBL] [Abstract][Full Text] [Related]
3. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer. Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K Front Immunol; 2022; 13():947802. PubMed ID: 36405735 [TBL] [Abstract][Full Text] [Related]
4. A novel clinical tool and risk stratification system for predicting the event-free survival of neuroblastoma patients: A TARGET-based study. Li M; Duan X; Li C; You D; Liu L Medicine (Baltimore); 2023 Sep; 102(38):e34925. PubMed ID: 37746942 [TBL] [Abstract][Full Text] [Related]
5. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses. Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183 [TBL] [Abstract][Full Text] [Related]
6. Expression Profiles and Prognostic Value of Multiple Inhibitory Checkpoints in Head and Neck Lymphoepithelioma-Like Carcinoma. Zou WQ; Luo WJ; Feng YF; Liu F; Liang SB; Fang XL; Liang YL; Liu N; Wang YQ; Mao YP Front Immunol; 2022; 13():818411. PubMed ID: 35140722 [TBL] [Abstract][Full Text] [Related]
7. Nucleolin expression has prognostic value in neuroblastoma patients. Cangelosi D; Brignole C; Bensa V; Tamma R; Malaguti F; Carlini B; Giusto E; Calarco E; Perri P; Ribatti D; Fonseca NA; Moreira JN; Eva A; Amoroso L; Conte M; Garaventa A; Sementa AR; Corrias MV; Ponzoni M; Pastorino F EBioMedicine; 2022 Nov; 85():104300. PubMed ID: 36209521 [TBL] [Abstract][Full Text] [Related]
8. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes. Xu HH; Wang HL; Xing TJ; Wang XQ Front Immunol; 2022; 13():851622. PubMed ID: 35924232 [TBL] [Abstract][Full Text] [Related]
9. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma. Tian M; Yang J; Han J; He J; Liao W Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180 [TBL] [Abstract][Full Text] [Related]
10. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis. Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993 [TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of programmed cell death ligand-1 in neuroblastoma tissues]. Liao R; Sun XF; Zhen ZZ; Huang DS Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):735-740. PubMed ID: 30293276 [No Abstract] [Full Text] [Related]
12. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma. Wu P; Zheng Y; Wang Y; Wang Y; Liang N J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Stage 4 and Stage 4s Neuroblastoma Identifies Autophagy-Related Gene and LncRNA Signatures Associated With Prognosis. Meng X; Li H; Fang E; Feng J; Zhao X Front Oncol; 2020; 10():1411. PubMed ID: 32974147 [No Abstract] [Full Text] [Related]
14. Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma. Chen X; Ma H; Mo S; Zhang Y; Lu Z; Yu S; Chen J Front Immunol; 2022; 13():942154. PubMed ID: 35936015 [TBL] [Abstract][Full Text] [Related]
15. Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma. Shi Y; Li Z; Zhou Z; Liao S; Wu Z; Li J; Yin J; Wang M; Weng M PeerJ; 2022; 10():e12646. PubMed ID: 35116193 [TBL] [Abstract][Full Text] [Related]
16. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis. Liang X; Cheng Z; Chen X; Li J Front Genet; 2022; 13():955424. PubMed ID: 36046241 [No Abstract] [Full Text] [Related]
17. Cellular components in tumor microenvironment of neuroblastoma and the prognostic value. Zhong X; Zhang Y; Wang L; Zhang H; Liu H; Liu Y PeerJ; 2019; 7():e8017. PubMed ID: 31844563 [TBL] [Abstract][Full Text] [Related]
18. Radiomics-based prediction model for outcomes of PD-1/PD-L1 immunotherapy in metastatic urothelial carcinoma. Park KJ; Lee JL; Yoon SK; Heo C; Park BW; Kim JK Eur Radiol; 2020 Oct; 30(10):5392-5403. PubMed ID: 32394281 [TBL] [Abstract][Full Text] [Related]
19. Construction of a Prognostic Nomogram Based on Autophagy-Related Genes for Children With Neuroblastoma. Ye G; Wang Y Evol Bioinform Online; 2022; 18():11769343221120960. PubMed ID: 36046056 [TBL] [Abstract][Full Text] [Related]
20. Identification of an Autophagy-Related Risk Signature Correlates With Immunophenotype and Predicts Immune Checkpoint Blockade Efficacy of Neuroblastoma. Kang W; Hu J; Zhao Q; Song F Front Cell Dev Biol; 2021; 9():731380. PubMed ID: 34746127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]